Periodic Reporting for period 3 - EDIReX (EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts)

Counteracting high failure rates in oncology drug development and providing optimal therapeutic management of cancer patients require research models that properly recapitulate the complexity and diversity of human tumours. Patient-derived tumour xenografts (PDXs), established...